Why is Suven Life Scie. falling/rising?

As of 23-Jun, Suven Life Sciences Ltd is experiencing a decline in its stock price, currently at Rs 220.15, which reflects a decrease of Rs 6.8 or 3.0%. Today's price summary indicates that the stock has underperformed its sector by 2.99%, with an intraday low of Rs 218, marking a drop of 3.94%. Although the stock has shown strong long-term performance with a 121.39% return over the past year and a remarkable 463.76% increase over five years, it faces significant challenges. The company has reported operating losses and negative results for the last three consecutive quarters, with a substantial decline in net sales and a weak ability to service its debt, which negatively impacts investor sentiment.
In the broader market context, the stock's short-term performance has been notably poor, with a 1-week return of -11.37%, contrasting with a slight gain of 0.12% in the Sensex during the same period. This underperformance is compounded by a significant drop in investor participation, particularly from institutional investors, who have reduced their stake in the company. The stock's liquidity remains adequate, but the overall negative sentiment surrounding its financial health and declining sales growth suggests that the recent price movement is primarily driven by concerns over its long-term viability, despite its historical performance.